vs

Side-by-side financial comparison of Editas Medicine, Inc. (EDIT) and SOUTHERN FIRST BANCSHARES INC (SFST). Click either name above to swap in a different company.

SOUTHERN FIRST BANCSHARES INC is the larger business by last-quarter revenue ($31.8M vs $24.7M, roughly 1.3× Editas Medicine, Inc.). On growth, SOUTHERN FIRST BANCSHARES INC posted the faster year-over-year revenue change (26.1% vs -19.2%). SOUTHERN FIRST BANCSHARES INC produced more free cash flow last quarter ($29.9M vs $-36.4M). Over the past eight quarters, Editas Medicine, Inc.'s revenue compounded faster (366.9% CAGR vs 22.2%).

Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

First Community Bankshares, Inc. is a $2.43 billion bank holding company and the parent company of First Community Bank of Bluefield, Virginia, in the United States. As of 2012 First Community Bank had 45 locations in Virginia, West Virginia, and North Carolina, and two locations operating as Peoples Community Bank in Tennessee. As of April 21, 2023, First Community had $3.6 billion in assets.

EDIT vs SFST — Head-to-Head

Bigger by revenue
SFST
SFST
1.3× larger
SFST
$31.8M
$24.7M
EDIT
Growing faster (revenue YoY)
SFST
SFST
+45.3% gap
SFST
26.1%
-19.2%
EDIT
More free cash flow
SFST
SFST
$66.3M more FCF
SFST
$29.9M
$-36.4M
EDIT
Faster 2-yr revenue CAGR
EDIT
EDIT
Annualised
EDIT
366.9%
22.2%
SFST

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EDIT
EDIT
SFST
SFST
Revenue
$24.7M
$31.8M
Net Profit
$-5.6M
Gross Margin
Operating Margin
-31.3%
40.1%
Net Margin
-22.7%
Revenue YoY
-19.2%
26.1%
Net Profit YoY
87.6%
EPS (diluted)
$0.03
$1.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EDIT
EDIT
SFST
SFST
Q4 25
$24.7M
$31.8M
Q3 25
$7.5M
$31.1M
Q2 25
$3.6M
$28.6M
Q1 25
$4.7M
$26.5M
Q4 24
$30.6M
$25.2M
Q3 24
$61.0K
$23.8M
Q2 24
$513.0K
$23.1M
Q1 24
$1.1M
$21.3M
Net Profit
EDIT
EDIT
SFST
SFST
Q4 25
$-5.6M
Q3 25
$-25.1M
$8.7M
Q2 25
$-53.2M
$6.6M
Q1 25
$-76.1M
$5.3M
Q4 24
$-45.4M
Q3 24
$-62.1M
$4.4M
Q2 24
$-67.6M
$3.0M
Q1 24
$-62.0M
$2.5M
Operating Margin
EDIT
EDIT
SFST
SFST
Q4 25
-31.3%
40.1%
Q3 25
-325.4%
36.4%
Q2 25
-1440.6%
30.0%
Q1 25
-1635.1%
26.1%
Q4 24
-152.2%
27.3%
Q3 24
-107649.2%
24.1%
Q2 24
-14016.2%
17.0%
Q1 24
-5902.3%
15.9%
Net Margin
EDIT
EDIT
SFST
SFST
Q4 25
-22.7%
Q3 25
-333.0%
27.8%
Q2 25
-1487.8%
23.0%
Q1 25
-1633.5%
19.9%
Q4 24
-148.3%
Q3 24
-101870.5%
18.4%
Q2 24
-13178.8%
13.0%
Q1 24
-5458.1%
11.8%
EPS (diluted)
EDIT
EDIT
SFST
SFST
Q4 25
$0.03
$1.19
Q3 25
$-0.28
$1.07
Q2 25
$-0.63
$0.81
Q1 25
$-0.92
$0.65
Q4 24
$-0.55
$0.69
Q3 24
$-0.75
$0.54
Q2 24
$-0.82
$0.37
Q1 24
$-0.76
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EDIT
EDIT
SFST
SFST
Cash + ST InvestmentsLiquidity on hand
$146.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$27.3M
$368.7M
Total Assets
$186.5M
$4.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EDIT
EDIT
SFST
SFST
Q4 25
$146.6M
Q3 25
$165.6M
Q2 25
$178.5M
Q1 25
$221.0M
Q4 24
$269.9M
Q3 24
$265.1M
Q2 24
$279.1M
Q1 24
$296.2M
Total Debt
EDIT
EDIT
SFST
SFST
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$57.4M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
EDIT
EDIT
SFST
SFST
Q4 25
$27.3M
$368.7M
Q3 25
$13.5M
$356.3M
Q2 25
$19.2M
$345.5M
Q1 25
$62.4M
$337.6M
Q4 24
$134.3M
$330.4M
Q3 24
$175.6M
$326.5M
Q2 24
$232.0M
$318.7M
Q1 24
$294.4M
$315.3M
Total Assets
EDIT
EDIT
SFST
SFST
Q4 25
$186.5M
$4.4B
Q3 25
$201.8M
$4.4B
Q2 25
$210.6M
$4.3B
Q1 25
$263.7M
$4.3B
Q4 24
$341.6M
$4.1B
Q3 24
$327.6M
$4.2B
Q2 24
$384.8M
$4.1B
Q1 24
$440.3M
$4.1B
Debt / Equity
EDIT
EDIT
SFST
SFST
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.43×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EDIT
EDIT
SFST
SFST
Operating Cash FlowLast quarter
$-36.4M
$30.5M
Free Cash FlowOCF − Capex
$-36.4M
$29.9M
FCF MarginFCF / Revenue
-147.3%
93.8%
Capex IntensityCapex / Revenue
0.2%
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$62.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EDIT
EDIT
SFST
SFST
Q4 25
$-36.4M
$30.5M
Q3 25
$-30.8M
$14.5M
Q2 25
$-50.2M
$10.5M
Q1 25
$-47.8M
$7.6M
Q4 24
$-50.8M
$25.6M
Q3 24
$-52.6M
$26.3M
Q2 24
$-57.1M
$4.0M
Q1 24
$-49.9M
$-2.9M
Free Cash Flow
EDIT
EDIT
SFST
SFST
Q4 25
$-36.4M
$29.9M
Q3 25
$-31.3M
$14.4M
Q2 25
$10.4M
Q1 25
$-47.9M
$7.4M
Q4 24
$-51.3M
$24.8M
Q3 24
$-55.5M
$26.1M
Q2 24
$-60.6M
$3.9M
Q1 24
$-51.7M
$-3.2M
FCF Margin
EDIT
EDIT
SFST
SFST
Q4 25
-147.3%
93.8%
Q3 25
-414.6%
46.3%
Q2 25
36.3%
Q1 25
-1028.6%
28.1%
Q4 24
-167.6%
98.2%
Q3 24
-90998.4%
110.0%
Q2 24
-11804.3%
16.8%
Q1 24
-4558.9%
-15.0%
Capex Intensity
EDIT
EDIT
SFST
SFST
Q4 25
0.2%
1.8%
Q3 25
5.7%
0.3%
Q2 25
0.0%
0.3%
Q1 25
2.4%
0.5%
Q4 24
1.8%
3.1%
Q3 24
4788.5%
0.8%
Q2 24
681.1%
0.4%
Q1 24
164.8%
1.3%
Cash Conversion
EDIT
EDIT
SFST
SFST
Q4 25
Q3 25
1.67×
Q2 25
1.59×
Q1 25
1.44×
Q4 24
Q3 24
6.01×
Q2 24
1.32×
Q1 24
-1.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons